Annual report pursuant to Section 13 and 15(d)

Notes Payable (Details Textual)

v3.8.0.1
Notes Payable (Details Textual) - USD ($)
1 Months Ended 10 Months Ended 12 Months Ended
Jul. 05, 2016
Jul. 29, 2015
Mar. 31, 2015
Dec. 31, 2015
Dec. 31, 2017
Dec. 31, 2016
Debt Instrument [Line Items]            
Class of Warrants Or Rights Issued, Warrants Term   10 years        
Interest Expense, Debt       $ 0 $ 8,000 $ 895,000
Amortization of Debt Discount (Premium)       0 $ 0 $ 763,000
Working Capital Promissory Note [Member] | Fortress Biotech, Inc [Member]            
Debt Instrument [Line Items]            
Debt Instrument, Interest Rate, Stated Percentage           8.00%
Notes Payable, Related Parties, Current           $ 320,000
Interest Expense, Debt       $ 168,000   $ 253,000
National Securities Corporation Note [Member]            
Debt Instrument [Line Items]            
Debt Instrument, Interest Rate, Stated Percentage           8.00%
Interest Expense, Debt           $ 140,000
Percentage Of Contingently Issuable Warrants On Indebtedness Transferred 25.00%          
Debt Instrument, Face Amount $ 3,600,000          
Debt Related Commitment Fees and Debt Issuance Costs $ 129,000          
Amortization of Debt Discount (Premium)           $ 763,000
Debt Instrument, Interest Rate, Effective Percentage 23.10%          
Debt Instrument, Unamortized Discount $ 634,000          
National Securities Corporation Note [Member] | Fortress Biotech, Inc [Member]            
Debt Instrument [Line Items]            
Proceeds from Issuance of Debt     $ 10,000,000